Sign in

    Noah Colby

    Research Analyst at Jefferies

    Noah Colby is an analyst at Jefferies specializing in equity research with coverage focused on the financial technology and payments sector, including companies such as Visa, Mastercard, and PayPal. Known for his in-depth industry analysis, Colby has delivered actionable investment recommendations documented by strong success rates and competitive performance metrics on platforms like TipRanks, where he consistently ranks among the top quartile of analysts in returns generated for investors. He began his career as an associate at a boutique research firm before joining Jefferies in 2020 as a Vice President, later advancing to Senior Analyst, and holds Series 7, 63, and 86/87 FINRA registration. Colby has earned internal recognition at Jefferies for his prescient calls on market-moving earnings and continues to be a widely quoted expert in the fintech landscape.

    Noah Colby's questions to CareDx (CDNA) leadership

    Noah Colby's questions to CareDx (CDNA) leadership • Q4 2024

    Question

    Noah Colby from Jefferies asked about the path forward on litigation following the recent patent reversal, the company's capital allocation priorities given its cash position, and the expected ramp-up time for new sales hires.

    Answer

    CEO John Hanna stated that while an appeal in the litigation is likely, the company believes the patent invalidation is significant. He reiterated the capital allocation strategy: first, reinvest in the business for growth; second, seek strategic M&A; and third, use share buybacks. Hanna also noted that new sales hires typically take about six months to become fully effective.

    Ask Fintool Equity Research AI